Recent advances in Parkinson's disease therapy: use of monoamine oxidase inhibitors.
about
Effects of combined MAO-B inhibitors and levodopa vs. monotherapy in Parkinson's disease.Introduction to the special issue "Pharmacotherapies for the treatment of alcohol abuse and dependence" and a summary of patents targeting other neurotransmitter systems.Therapeutic interventions and adjustments in the management of Parkinson disease: role of combined carbidopa/levodopa/entacapone (Stalevo).Selegiline is an efficient and potent inducer for bone marrow stromal cell differentiation into neuronal phenotype.
P2860
Recent advances in Parkinson's disease therapy: use of monoamine oxidase inhibitors.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Recent advances in Parkinson's disease therapy: use of monoamine oxidase inhibitors.
@ast
Recent advances in Parkinson's disease therapy: use of monoamine oxidase inhibitors.
@en
type
label
Recent advances in Parkinson's disease therapy: use of monoamine oxidase inhibitors.
@ast
Recent advances in Parkinson's disease therapy: use of monoamine oxidase inhibitors.
@en
prefLabel
Recent advances in Parkinson's disease therapy: use of monoamine oxidase inhibitors.
@ast
Recent advances in Parkinson's disease therapy: use of monoamine oxidase inhibitors.
@en
P2093
P2860
P356
P1476
Recent advances in Parkinson's disease therapy: use of monoamine oxidase inhibitors.
@en
P2093
Claire Henchcliffe
F Tuna Burgut
H Christian Schumacher
P2860
P304
P356
10.1586/14737175.5.6.811
P577
2005-11-01T00:00:00Z